Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic COVID-19-related research market cap changes in biopharma companies Feb 2020
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Basic Statistic U.S. venture investments in infectious disease companies 2006-2023
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2024
- Premium Statistic Clinical CRO market share worldwide by company 2016
- Premium Statistic Members of EFPIA's pharmaceutical R&D spending 1990-2022
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
About the region
10
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by phase June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by type June 2022
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Premium Statistic Number of registered COVID-19 studies worldwide Apr 2020 - Dec 2022, by region
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
- Premium Statistic Global AI-enabled drug discovery and clinical trials market by region 2030
- Premium Statistic Leading global contract research organizations based on revenue 2022
- Basic Statistic Percentage return on R&D among mid cap biopharma companies 2013-2020
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Basic Statistic YTD stock performance of biopharma companies working on COVID March 2020
- Basic Statistic Spending on R&D from pharmaceutical industry in Canada 2004-2022
- Premium Statistic Revenue generated by high-tech companies through new products 2021, by industry
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Share of sales attributable to new active substances launched 2016-2020 by country
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Mexico: pharmaceutical expenditure 2012-2018
- Basic Statistic Latino COVID-19 deaths vs population in select U.S. states as of June 23, 2020
- Basic Statistic UK pharmaceutical businesses: R&D expenditure 2002-2021
- Premium Statistic R&D spending in the pharmaceutical industry in Argentina 2016-2020
Related statistics
10
- Premium Statistic Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
- Basic Statistic Number of cell and gene therapy deals worldwide 2016-2020, by type
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Basic Statistic CRO market size worldwide forecast 2032
- Basic Statistic Presumed benefits of participation in clinical trials among adults worldwide in 2019
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Basic Statistic Global biologics discovery market worldwide by phase 2016-2025
- Premium Statistic Reasons why clinical trial organizations use direct-to-patient distribution 2016
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- MorphoSys' research & development expenditure 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- MorphoSys' research & development expenditure 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Vantage. (February 27, 2020). Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. "Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020." Chart. February 27, 2020. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. (2020). Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020. Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. "Share Price Changes of Select Biopharmaceutical Companies Involved in Coronavirus (Covid-19) Research from January 20 to February 25, 2020." Statista, Statista Inc., 27 Feb 2020, https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage, Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 Statista, https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/ (last visited June 01, 2024)
Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 [Graph], Vantage, February 27, 2020. [Online]. Available: https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/